Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Carretera de Colmenar, Km 9.1, 28034, Madrid, Spain.
Diabetes, Obesity and Human Reproduction Research Group, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
Cardiovasc Diabetol. 2023 Feb 15;22(1):32. doi: 10.1186/s12933-023-01766-y.
Sex differences characterize cardiovascular outcomes in patients with type 1 diabetes. Cardioautonomic neuropathy is a common complication of type 1 diabetes that associates increased morbi-mortality. Data regarding the interplay between sex and cardiovascular autonomic neuropathy are scarce and controversial in these patients. We aimed to address sex-related differences in the prevalence of seemingly asymptomatic cardioautonomic neuropathy in type 1 diabetes, and their associations with sex steroids.
We conducted a cross-sectional study including 322 consecutively recruited patients with type 1 diabetes. Cardioautonomic neuropathy was diagnosed using Ewing's score and power spectral heart rate data. We assessed sex hormones by liquid chromatography/tandem mass spectrometry.
When considering all subjects as a whole, asymptomatic cardioautonomic neuropathy prevalence was not significantly different between women and men. When age was taken into account, the prevalence of cardioautonomic neuropathy was similar among young men and those > 50 years. However, in women > 50 years, the prevalence of cardioautonomic neuropathy doubled that of young women [45.8% (32.6; 59.7) vs. 20.4% (13.7; 29.2), respectively]. The OR of having cardioautonomic neuropathy was 3.3 higher in women > 50 years than in their younger counterparts. Furthermore, women presented more severe cardioautonomic neuropathy than men. These differences were even more marked when women were classified according their menopausal status instead of age. Peri- and menopausal women had an OR 3.5 (1.7; 7.2) of having CAN compared with their reproductive-aged counterparts [CAN prevalence: 51% (37; 65) vs. 23% (16; 32), respectively]. A binary logistic regression model (R: 0.161; P = 0.001) displayed age > 50 years as a significant determinant of cardioautonomic neuropathy only in women. Androgens were positively associated with heart rate variability in men, and negatively in women. Accordingly, cardioautonomic neuropathy was associated with increased testosterone/estradiol ratio in women but to decreased testosterone concentrations in men.
Menopause in women with type 1 diabetes is accompanied by an increase in the prevalence of asymptomatic cardioautonomic neuropathy. This age-related excess risk of cardioautonomic neuropathy is not observed in men. Men and women with type 1 diabetes have opposite associations between circulating androgens and indexes of cardioautonomic function. Trial registration ClinicalTrials.gov Identifier: NCT04950634.
1 型糖尿病患者的心血管结局存在性别差异。心脏自主神经病变是 1 型糖尿病的常见并发症,与死亡率和发病率增加相关。关于 1 型糖尿病患者中性别与心血管自主神经病变之间相互作用的数据稀缺且存在争议。我们旨在探讨 1 型糖尿病患者中看似无症状的心脏自主神经病变的患病率是否存在性别差异,以及它们与性激素之间的关系。
我们进行了一项横断面研究,纳入了 322 例连续招募的 1 型糖尿病患者。使用 Ewing 评分和功率谱心率数据诊断心脏自主神经病变。我们通过液相色谱/串联质谱法评估性激素。
当将所有受试者作为一个整体考虑时,女性和男性之间无症状心脏自主神经病变的患病率没有显著差异。当考虑年龄时,年轻男性和 50 岁以上男性的心脏自主神经病变患病率相似。然而,在 50 岁以上的女性中,心脏自主神经病变的患病率是年轻女性的两倍[分别为 45.8%(32.6;59.7)和 20.4%(13.7;29.2)]。50 岁以上女性发生心脏自主神经病变的比值比(OR)是年轻女性的 3.3 倍。此外,女性的心脏自主神经病变比男性更严重。当根据绝经状态而不是年龄对女性进行分类时,这些差异更为明显。围绝经期和绝经后女性发生 CAN 的 OR 为 3.5(1.7;7.2),与生育期女性相比[CAN 患病率:51%(37;65)与 23%(16;32)]。二元逻辑回归模型(R:0.161;P=0.001)显示,50 岁以上的年龄是女性发生心脏自主神经病变的显著决定因素。雄激素与男性的心率变异性呈正相关,与女性呈负相关。因此,女性的心脏自主神经病变与睾酮/雌二醇比值增加有关,而男性的心脏自主神经病变与睾酮浓度降低有关。
1 型糖尿病女性绝经后无症状心脏自主神经病变的患病率增加。这种与年龄相关的女性心脏自主神经病变风险增加在男性中并未观察到。1 型糖尿病男性和女性的循环雄激素与心脏自主神经功能指标之间存在相反的关联。
ClinicalTrials.gov 标识符:NCT04950634。